BioCentury
ARTICLE | Company News

Orexigen names Narachi CEO

April 2, 2009 12:58 AM UTC

Obesity company Orexigen Therapeutics Inc. (NASDAQ:OREX) hired Michael Narachi as president and CEO. Previously, Narachi was chairman, president and CEO of Ren Pharmaceuticals Inc. (South San Francisc...